Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Apr 16;2008(2):CD005443.
doi: 10.1002/14651858.CD005443.pub2.

Antacids for preventing oesophagogastric variceal bleeding and rebleeding in cirrhotic patients

J Yang, Z Guo, Z Wu, Y Wang

Antacids for preventing oesophagogastric variceal bleeding and rebleeding in cirrhotic patients

J Yang et al. Cochrane Database Syst Rev. .

Abstract

Background: Ruptured gastroesophageal varices are the most severe and frequent cause of gastrointestinal bleeding in cirrhotic patients, leading to death in 5% to 8% of patients during the first 48 hours and oesophagogastric varices account for 60% to 80% of first bleeding in patients with portal hypertension. Antacids are often used for emergency treatment of bleeding oesophageal varices in patients with cirrhosis of the liver.

Objectives: To evaluate the beneficial and harmful effects of antacids for preventing oesophagogastric bleeding and rebleeding.

Search strategy: We identified relevant randomised clinical trials by searching The Cochrane Hepato-Biliary Group Controlled Trials Register (June 2007), the Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library (Issue 2, 2007), MEDLINE (1950 to June 2007), EMBASE (Excerpta Medica Database) (1980 to June 2007), and the Science Citation Index Expanded (SCI-EXPANDED) (1945 to June 2007). Additional randomised trials were sought from the reference lists of the trials found and reviews identified by the electronic searches.

Selection criteria: We planned to include randomised clinical trials.

Data collection and analysis: We planned to summarise data using Cochrane Collaboration methodologies.

Main results: We could not find any randomised clinical trials on antacids for preventing oesophagogastric variceal bleeding and bleeding in cirrhotic patients.

Authors' conclusions: it is not possible to determine whether antacids are beneficially effective or harmful for preventing oesophagogastric variceal bleeding and rebleeding in cirrhotic patients since randomised clinical trials investigating it are lacking.

PubMed Disclaimer

Conflict of interest statement

None known.

Update of

References

References to studies excluded from this review

Andersen 1983 {published data only}
    1. Andersen OK, Farup P, Hasvoll A, Bernklev T. Patient compliance to intensive antacid treatment. Scandinavian Journal of Gastroenterology 1983;86:3. - PubMed
Attwell 2005 {published data only}
    1. Attwell AR, Chen YK. Endoscopic ligation in the treatment of variceal bleeding. Techniques in Gastrointestinal Endoscopy 2005;7(1):18‐25.
Bachir 1981 {published data only}
    1. Bachir GS, Leigh Collis J, Wilson P, Pollak EW. Diagnosis of incipient reflux esophagitis: a new test. Southern Medical Journal 1981;74(9):1072‐4. - PubMed
Jackson 2003 {published data only}
    1. Jackson R, Pencharz PB. Cystic fibrosis. Bailliere's Best Practice and Research in Clinical Gastroenterology 2003;17(2):213‐35. - PubMed
Kumar 1984 {published data only}
    1. Kumar N, Vij JC, Karol A, Anand BS. Controlled therapeutic trial to determine the optimum dose of antacids in duodenal ulcer. Gut 1984;25(11):1199‐202. - PMC - PubMed
Londong 1983 {published data only}
    1. Londong W. Drug therapy and prevention of acute upper gastrointestinal hemortroenterologie. Zeitschrift für Gastroenterologie 1983;21(6):282‐9. - PubMed
Macdougall 1977 {published data only}
    1. Macdougall BR, Bailey RJ, Williams R. H2‐receptor antagonists and antacids in the prevention of acute gastrointestinal haemorrhage in fulminant hepatic failure Two controlled trials. Lancet 1977 1977;1(8012):617‐9. - PubMed
Meshkinpour 1977 {published data only}
    1. Meshkinpour H, Elashoff J, Stewart H 3rd, Sturdevant RA. Effect of cholestyramine on the symptoms of reflux gastritis A randomized, double blind, crossover study. Gastroenterology 1977;73(3):441‐3. - PubMed
Narendranathan 1999 {published data only}
    1. Narendranathan M, Remla A, Mini PC, Satheesh P. A trial of Phyllanthus Amarus in acute viral hepatitis. Tropical Gastroenterology 1999;20(4):164‐6. - PubMed
Priebe 1980 {published data only}
    1. Priebe HJ, Skillman JJ, Bushnell LS, Long PC, Silen W. Antacid versus cimetidine in preventing acute gastrointestinal bleeding A randomized trial in 75 critically ill patients. New England Journal of Medicine 1980;302(8):426‐30. - PubMed
Snady 1989 {published data only}
    1. Snady H, Rosman AS, Korsten MA. Prevention of stricture formation after endoscopic sclerotherapy of esophageal varices. Gastrointestinal Endoscopy 1989;35(5):377‐80. - PubMed
Winston 2002 {published data only}
    1. Winston DJ, Busuttil RW. Randomized controlled trial of oral itraconazole solution versus intravenous/oral fluconazole for prevention of fungal infections in liver transplant recipients. Transplantation 2002;74(5):688‐95. - PubMed
Yang 1998 {published data only}
    1. Yang WG, Hou MC, Lin HC, Kuo BI, Lee FY, Chang FY, et al. Effect of sucralfate granules in suspension on endoscopic variceal sclerotherapy induced ulcer: analysis of the factors determining ulcer healing. Journal of Gastroenterology and Hepatology 1998;13(2):225‐31. - PubMed
Zuckerman 1984 {published data only}
    1. Zuckerman G, Welch R, Douglas A, Troxell R, Cohen S, Lorber S, et al. Controlled trial of medical therapy for active upper gastrointestinal bleeding and prevention of rebleeding. American Journal of Medicine 1984;76(3):361‐6. - PubMed

Additional references

Alderson 2004
    1. Alderson P. Absence of evidence is not evidence of absence. BMJ (Clinical Research Ed.) 2004;328:476‐7. - PMC - PubMed
Amitrano 2002
    1. Amitrano L, Guardascione MA, Brancaccio V, Balzano A. Coagulation disorders in liver disease. Seminars in Liver Disease 2002;22:83‐96. - PubMed
Bosch 2004
    1. Bosch J, Abraldes JG. Management of gastrointestinal bleeding in patients with cirrhosis of the liver. Seminars in Hematology 2004;41(1 (Suppl)):8‐12. - PubMed
Chalmers 2004
    1. Chalmers I. Well informed uncertainties about the effects of treatments. How clinicians and patients respond?. BMJ (Clinical Research Ed.) 2004;328:475‐6. - PMC - PubMed
D'Amico 2003
    1. D'Amico G, Franchis R, Cooperative Study Group. Upper digestive bleeding in cirrhosis. Post‐therapeutic outcome and prognostic indicators. Hepatology 2003;38(3):599‐612. - PubMed
Dagher 2001
    1. Dagher L, Burroughs A. Variceal bleeding and portal hypertensive gastropathy. European Journal of Gastroenterology & Hepatology 2001;13:81‐8. - PubMed
de Franchis 2001
    1. Franchis R. What have we accomplished?. Portal hypertention III: Proceedings of the third Baveno international consensus workshop on definitions, methodology and therapeutic strategies. Oxford: Blackwell Science, 2001:1‐12.
Easterbrook 1991
    1. Easterbrook PJ, Berlin J, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet 1991;337:867‐72. - PubMed
Gluud 1998
    1. Gluud C. "Negative trials" are positive!. Journal of Hepatology 1998;28(4):731‐3. - PubMed
Gluud 2001
    1. Gluud C. Alcoholic hepatitis: no glucorticocosteroids?. Steatohepatitis (NASH and ASH) ‐ Falk Symposium No 121. Lancaster: Kluwer Academic Publisher, 2001:322‐42.
Gluud 2007
    1. Gluud C, Nikolova D, Klingenberg SL, Als‐Nielsen B, D'Amico G, Davidson B, et al. Cochrane Hepato‐Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2007, Issue 2. Art. No.: LIVER.
Green 2003
    1. Green BT, Rockey DC. Acute gastrointestinal bleeding. Seminars in Gastrointestinal Disease 2003;14:44‐65. - PubMed
Higgins 2006
    1. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]. The Cochrane Library, Issue 4, 2006. Chichester, UK: John Wiley & sons, Ltd, 2006.
ICH‐GCP 1997
    1. International Conference on Harmonisation Expert Working Group. Code of Federal Regulations & International Conference on Harmonization Guidelines. Media: Parexel Barnett, 1997.
Ioannidis 2004
    1. Ioannidis JP, Evans SJ, Gotzsche PC, O'Neill RT, Altman DG, Schulz K, et al. Better reporting of harms in randomized trials: an extension of the CONSORT statement. Annals of Internal Medicine 2004;141(10):781‐8. - PubMed
Kjaergard 2001
    1. Kjaergard LL, Villumsen J, Gluud C. Reported methodological quality and discrepancies between large and small randomised trials in meta‐analyses. Annals of Internal Medicine 2001;135:982‐9. - PubMed
MacDougall 1977
    1. MacDougall BRD, Bailey RJ, Williams R. H2‐receptor antagonists and antacids in the prevention of acute gastrointestinal haemorrhage in fulminant hepatic failure. Two controlled trials. Lancet 1977;19(1):617‐9. - PubMed
Moher 1998
    1. Moher D, Jadad AR, Moher M. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta‐analyses?. Lancet 1998;352:609‐13. - PubMed
Moher 2004
    1. Moher D, Altman DG, Schulz KF, Elbourne DR. Opportunities and challenges for improving the quality of reporting clinical research: CONSORT and beyond. Canadian Medical Association Journal 2004;171(14):349‐50. - PMC - PubMed
Pique 1988
    1. Pique JM, Leung FW, Kitahora T, Sarfeh IJ, Tarnawski A, Guth PH. Gastric mucosal blood flow and acid secretion in portal hypertensive rats. Gastroenterology 1988;95:727‐33. - PubMed
Pugh 1973
    1. Pugh RNH, Murray‐Lyon IM, Dawson JL, Pietoni MC, Williams R. Transection of the esophagus for bleeding esophageal varices. British Journal of Surgery 1973;60(8):648‐52. - PubMed
RevMan 2003 [Computer program]
    1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 4.2 for Windows. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2003.
Royle 2003
    1. Royle P, Milne R. Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches. International Journal of Technology Assessment in Health Care 2003;19(4):591‐603. - PubMed
Schulz 1995
    1. Schulz KF, Chalmers I, Hayers RJ, Altman DG. Emprirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408‐12. - PubMed
Smart 1991
    1. Smart HJ, Trigger DR. Clinical features, pathophysiology and relevence of portal hypertensive gastropathy. Endoscopy 1991;23:224‐8. - PubMed
Triger 1989
    1. Triger DR. Natural history and treatment of portal hypertensive gastropathy. Journal of Gastroenterology and Hepatology 1989;1(suppl):8‐14. - PubMed
Zeng 1998
    1. Zeng MD. Forecast and treatment of esophageal variceal. Chinese Journal of Liver and Gallbladder 1998;6:65‐6.
Zhou 2002
    1. Zhou YN, Liang Q, Jing W, Hu HW, Xu CP. Comparison of the efficacy of octreotide, vasopressin, and omeprazole in the control of acute bleeding in patients with portal hypertensive gastropathy: a controlled study. Journal of Gastroenterology and Hepatology 2002;17:973‐9. - PubMed

Publication types

MeSH terms